![Philip Huang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philip Huang
Vorstandsvorsitzender bei
TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED
Profil
Kuo Long Huang is currently the Chairman, Chief Executive Officer, General Manager, and Spokesman at TaiGen Biopharmaceuticals Holdings Ltd. He started this position in 2019.
Prior to his current role, he has a background in business administration, having obtained an MBA from the University of South Australia.
He also has an undergraduate degree from Taipei Medical University.
Aktive Positionen von Philip Huang
| Unternehmen | Position | Beginn |
|---|---|---|
| TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Vorstandsvorsitzender | 02.01.2019 |
Ausbildung von Philip Huang
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
16
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
University of South Australia
 University of South Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Taipei Medical University
 Taipei Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TaiGen Biopharmaceuticals Holdings Ltd.
 TaiGen Biopharmaceuticals Holdings Ltd. BiotechnologyHealth Technology Develops novel therapeutics for infectious diseases, cancer, and diabetes-related complications | Health Technology |
